STUDY OBJECTIVES: We evaluated the role of sputum examination in the management of patients with community-acquired pneumonia (CAP) in a primary-care hospital without microbiologic laboratory facilities. DESIGN AND INTERVENTIONS: A diagnostic strategy using regular collection of sputum samples, Gram staining in a local laboratory, and mailing of samples to a commercial laboratory for culture analysis. SETTING: A 200-bed primary-care hospital without subspeciality physicians. PATIENTS: One hundred sixteen consecutive patients with a diagnosis of CAP were prospectively evaluated during a 12-month period. RESULTS: Of 116 patients, 42 patients (36%) were capable of producing a sputum sample. Age > or = 75 years (odds ratio [OR], 0.4; 95% confidence interval [CI], 0.18 to 0.93) and prior ambulatory antimicrobial treatment (OR, 3.2; 95% CI, 1.2 to 8.4) were independent predictors of sputum production. A delay in collection and processing of sputum samples of > 24 h was present in 31% and 39%, respectively. A delay in collection yielded an increased number of Gram-negative enteric bacilli and nonfermenters (44% vs. 7%, p = 0.056). A delay in processing was associated with an increased number of Candida spp isolates (33% vs. 9%, p = 0.16). The overall diagnostic yield was low (10 of 116 patients, 9%) due to a limited number of valid samples (n = 23 of 42 patients, 55%) and a limited number of definitely or probably positive samples on Gram's stain and culture (n = 10 of 42 patients, 24%). Prior ambulatory antimicrobial treatment was associated with a reduction in diagnostic yield (14% vs. 56%, p = 0.09). The impact of diagnostic results on antimicrobial treatment decisions was minimal, with antimicrobial treatment directed to diagnostic results in only one patient. CONCLUSIONS: We conclude that in this setting representative of primary-care hospitals in Germany, sputum had a low diagnostic yield and did not contribute significantly to patient management.
STUDY OBJECTIVES: We evaluated the role of sputum examination in the management of patients with community-acquired pneumonia (CAP) in a primary-care hospital without microbiologic laboratory facilities. DESIGN AND INTERVENTIONS: A diagnostic strategy using regular collection of sputum samples, Gram staining in a local laboratory, and mailing of samples to a commercial laboratory for culture analysis. SETTING: A 200-bed primary-care hospital without subspeciality physicians. PATIENTS: One hundred sixteen consecutive patients with a diagnosis of CAP were prospectively evaluated during a 12-month period. RESULTS: Of 116 patients, 42 patients (36%) were capable of producing a sputum sample. Age > or = 75 years (odds ratio [OR], 0.4; 95% confidence interval [CI], 0.18 to 0.93) and prior ambulatory antimicrobial treatment (OR, 3.2; 95% CI, 1.2 to 8.4) were independent predictors of sputum production. A delay in collection and processing of sputum samples of > 24 h was present in 31% and 39%, respectively. A delay in collection yielded an increased number of Gram-negative enteric bacilli and nonfermenters (44% vs. 7%, p = 0.056). A delay in processing was associated with an increased number of Candida spp isolates (33% vs. 9%, p = 0.16). The overall diagnostic yield was low (10 of 116 patients, 9%) due to a limited number of valid samples (n = 23 of 42 patients, 55%) and a limited number of definitely or probably positive samples on Gram's stain and culture (n = 10 of 42 patients, 24%). Prior ambulatory antimicrobial treatment was associated with a reduction in diagnostic yield (14% vs. 56%, p = 0.09). The impact of diagnostic results on antimicrobial treatment decisions was minimal, with antimicrobial treatment directed to diagnostic results in only one patient. CONCLUSIONS: We conclude that in this setting representative of primary-care hospitals in Germany, sputum had a low diagnostic yield and did not contribute significantly to patient management.
Authors: Alexey Ruzin; Olivier Barraud; Li Yu; Bruno François; Miguel Sánchez-Garcia; Philippe Eggimann; Pierre-François Dequin; Pierre-François Laterre; Vincent Huberlant; Lucia Viña; Thierry Boulain; Cedric Bretonniere; Jérôme Pugin; José Trenado; Ana Catalina Hernandez Padilla; Julie Vignaud; Drieke Vandamme; Herman Goossens; Christine Lammens; S Omar Ali; Kathryn Shoemaker; Pin Ren; Susan Colbert; Terramika Bellamy; Bret R Sellman; Michael McCarthy; Hasan S Jafri; Mark T Esser Journal: J Clin Microbiol Date: 2022-06-27 Impact factor: 11.677
Authors: Barbara Ellen Jones; Jian Ying; Vanessa Stevens; Candace Haroldsen; Tao He; McKenna Nevers; Matthew A Christensen; Richard E Nelson; Gregory J Stoddard; Brian C Sauer; Peter M Yarbrough; Makoto M Jones; Matthew Bidwell Goetz; Tom Greene; Matthew H Samore Journal: JAMA Intern Med Date: 2020-04-01 Impact factor: 21.873
Authors: M H Rozenbaum; P Pechlivanoglou; T S van der Werf; J R Lo-Ten-Foe; M J Postma; E Hak Journal: Eur J Clin Microbiol Infect Dis Date: 2012-12-14 Impact factor: 3.267
Authors: Jonathan M Wortham; Jennifer Gray; Jennifer Verani; Carmen Lucia Contreras; Chris Bernart; Fabiola Moscoso; Juan Carlos Moir; Emma Lissette Reyes Marroquin; Rigoberto Castellan; Wences Arvelo; Kim Lindblade; John P McCracken Journal: PLoS One Date: 2015-07-24 Impact factor: 3.240
Authors: Elisabeth G W Huijskens; John W A Rossen; Jan A J W Kluytmans; Adri G M van der Zanden; Marion Koopmans Journal: Influenza Other Respir Viruses Date: 2013-08-20 Impact factor: 4.380